Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-129778
Filing Date
2024-12-18
Accepted
2024-12-18 16:31:27
Documents
1
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2431489-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2431489-2_4seq1.xml 4 4167
  Complete submission text file 0001104659-24-129778.txt   5724
Mailing Address C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Business Address
Fox Jennifer A. (Reporting) CIK: 0001841557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42270 | Film No.: 241559695

Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)